Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Apparently “a lot” of people were axed today at Morgan Stanley, with cuts occurring “across the board, not just bad FAs, as was previously assumed. Fixed income and equity areas have gotten the boot as well.”
That’s all we know at this time; if you have anything else to add, don’t be a stranger.
UPDATE: According to spokesman Mark Lake, “we have no plans for cuts in our institutional securities business (IBD, FID or equity).”